<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32331311</PMID><DateCompleted><Year>2021</Year><Month>01</Month><Day>25</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>25</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>8</Issue><PubDate><Year>2020</Year><Month>Apr</Month><Day>22</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>PACAP Modulates the Autophagy Process in an In Vitro Model of Amyotrophic Lateral Sclerosis.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2943</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms21082943</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease of complex etiology leading to motor neuron degeneration. Many gene alterations cause this pathology, including mutation in Cu, Zn superoxide dismutase (SOD1), which leads to its gain of function. Mutant SOD1 proteins are prone to aberrant misfolding and create aggregates that impair autophagy. The hypoxic stress is strictly linked to the disease progression since it induces uncontrolled autophagy activation and the consequent high rates of cell death. Previously, we showed that pituitary adenylate cyclase-activating polypeptide (PACAP) exerts neurotrophic activity in cultured mSOD1 motor neurons exposed to serum deprivation. To date, no studies have examined whether the protective effect of PACAP on mSOD1 cells exposed to hypoxic insult is mediated through the regulation of the autophagy process. In the present study, we used the neuroblastoma-spinal cord-34 (NSC-34) cell line, stably expressing human wild type or mutant SOD1 G93A, to represent a well characterized in vitro model of a familial form of ALS. These cells were exposed to 100-&#xb5;M desferrioxamine mesylate salt for 24h, to mimic the hypoxic stress affecting motor neurons during the disease progression. Our results showed that PACAP treatment significantly reduced cell death and hypoxia-induced mSOD1 accumulation by modulating the autophagy process in G93A motor neurons, as revealed by the decreased LC3II and the increased p62 levels, two autophagy indicators. These results were also confirmed by evaluating the vacuole formation detected through light chain 3 (LC3) immunofluorescence. Furthermore, the PACAP effects on autophagy seem to be mediated through the activation of the MAPK/ERK signaling pathway. Overall, our data demonstrated that PACAP exerts an ameliorative effect on the mSOD1 motor neuron viability by modulating a hypoxia-induced autophagy process through activation of MAPK/ERK signaling cascade.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>D'Amico</LastName><ForeName>Agata Grazia</ForeName><Initials>AG</Initials><AffiliationInfo><Affiliation>Department of Human Science and Promotion of quality of Life, San Raffaele Open University of Rome, Via di Val Cannuta, 247, 00166 Roma, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maugeri</LastName><ForeName>Grazia</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Section of Human Anatomy and Histology, Department of Biomedical and Biotechnological Sciences, University of Catania, Via S. Sofia, 87, 95123 Catania, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saccone</LastName><ForeName>Salvatore</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Section of Animal Biology, Department of Biological, Geological and Environmental Sciences, University of Catania, 95123 Catania, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Federico</LastName><ForeName>Concetta</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Section of Animal Biology, Department of Biological, Geological and Environmental Sciences, University of Catania, 95123 Catania, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cavallaro</LastName><ForeName>Sebastiano</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute for Biomedical Research and Innovation, Italian National Research Council, 95123 Catania, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reglodi</LastName><ForeName>Dora</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Anatomy, MTA-PTE PACAP Research Group, University of Pecs Medical School, 7622 P&#xe9;cs, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>D'Agata</LastName><ForeName>Velia</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Section of Human Anatomy and Histology, Department of Biomedical and Biotechnological Sciences, University of Catania, Via S. Sofia, 87, 95123 Catania, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>04</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051219">Pituitary Adenylate Cyclase-Activating Polypeptide</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000606290">SOD1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001343" MajorTopicYN="Y">Autophagy</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002470" MajorTopicYN="N">Cell Survival</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004198" MajorTopicYN="N">Disease Susceptibility</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000860" MajorTopicYN="N">Hypoxia</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020935" MajorTopicYN="N">MAP Kinase Signaling System</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051219" MajorTopicYN="N">Pituitary Adenylate Cyclase-Activating Polypeptide</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">PACAP</Keyword><Keyword MajorTopicYN="N">autophagy process</Keyword><Keyword MajorTopicYN="N">hypoxia condition</Keyword></KeywordList><CoiStatement>Authors declare no conflict of interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>2</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>4</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>4</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>4</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>4</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>1</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32331311</ArticleId><ArticleId IdType="pmc">PMC7216177</ArticleId><ArticleId IdType="doi">10.3390/ijms21082943</ArticleId><ArticleId IdType="pii">ijms21082943</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wong P.C., Rothstein J.D., Price D.L. The genetic and molecular mechanisms of motor neuron disease. Curr. Opin. Neurobiol. 1998;8:791&#x2013;799. doi: 10.1016/S0959-4388(98)80123-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0959-4388(98)80123-2</ArticleId><ArticleId IdType="pubmed">9914243</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen D.K.H., Thombre R., Wang J. Autophagy as a common pathway in amyotrophic lateral sclerosis. Neurosci. Lett. 2018;697:34&#x2013;48. doi: 10.1016/j.neulet.2018.04.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2018.04.006</ArticleId><ArticleId IdType="pmc">PMC6170747</ArticleId><ArticleId IdType="pubmed">29626651</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S., Sayana P., Zhang X., Le W. Genetics of amyotrophic lateral sclerosis: An update. Mol. Neurodegener. 2013;8:28. doi: 10.1186/1750-1326-8-28.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1326-8-28</ArticleId><ArticleId IdType="pmc">PMC3766231</ArticleId><ArticleId IdType="pubmed">23941283</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruijn L., Houseweart M.K., Kato S., Anderson K.L., Anderson S.D., Ohama E., Reaume A.G., Scott R.W., Cleveland D.W. Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1. Science. 1998;281:1851&#x2013;1854. doi: 10.1126/science.281.5384.1851.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.281.5384.1851</ArticleId><ArticleId IdType="pubmed">9743498</ArticleId></ArticleIdList></Reference><Reference><Citation>Robberecht W., Philips T. The changing scene of amyotrophic lateral sclerosis. Nat. Rev. Neurosci. 2013;14:248&#x2013;264. doi: 10.1038/nrn3430.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn3430</ArticleId><ArticleId IdType="pubmed">23463272</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirby J., Halligan E., Baptista M.J., Allen S., Heath P.R., Holden H., Barber S.C., Loynes C.A., Wood-Allum C.A., Lunec J., et al. Mutant SOD1 alters the motor neuronal transcriptome: Implications for familial ALS. Brain. 2005;128:1686&#x2013;1706. doi: 10.1093/brain/awh503.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awh503</ArticleId><ArticleId IdType="pubmed">15872021</ArticleId></ArticleIdList></Reference><Reference><Citation>Song C.-Y., Guo J., Liu Y., Tang B.-S. Autophagy and Its Comprehensive Impact on ALS. Int. J. Neurosci. 2012;122:695&#x2013;703. doi: 10.3109/00207454.2012.714430.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/00207454.2012.714430</ArticleId><ArticleId IdType="pubmed">22827270</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei Y.-M. Autophagic induction of amyotrophic lateral sclerosis-linked Cu/Zn superoxide dismutase 1 G93A mutant in NSC34 cells. Neural Regen. Res. 2014;9:16&#x2013;24. doi: 10.4103/1673-5374.125325.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1673-5374.125325</ArticleId><ArticleId IdType="pmc">PMC4146317</ArticleId><ArticleId IdType="pubmed">25206739</ArticleId></ArticleIdList></Reference><Reference><Citation>Hara T., Nakamura K., Matsui M., Yamamoto A., Nakahara Y., Suzuki-Migishima R., Yokoyama M., Mishima K., Saito I., Okano H., et al. Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature. 2006;15:885&#x2013;889. doi: 10.1038/nature04724.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature04724</ArticleId><ArticleId IdType="pubmed">16625204</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsueh K.-W., Chiou T.-W., Chiang S.-F., Yamashita T., Abe K., Borlongan C.V., Sanberg P.R., Huang A., Yu H., Lin S.-Z., et al. Autophagic down-regulation in motor neurons remarkably prolongs the survival of ALS mice. Neuropharmacology. 2016;108:152&#x2013;160. doi: 10.1016/j.neuropharm.2016.03.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuropharm.2016.03.035</ArticleId><ArticleId IdType="pubmed">27059126</ArticleId></ArticleIdList></Reference><Reference><Citation>Tu P.H., Raju P., Robinson K.A., Gurney M.E., Trojanowski J.Q., Lee V.M. Transgenic mice carrying a human mutant superoxide dismutase transgene develop neuronal cytoskeletal pathology resembling human amyotrophic lateral sclerosis lesions. Proc. Natl. Acad. Sci. USA. 1996;93:3155&#x2013;3160. doi: 10.1073/pnas.93.7.3155.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.93.7.3155</ArticleId><ArticleId IdType="pmc">PMC39778</ArticleId><ArticleId IdType="pubmed">8610185</ArticleId></ArticleIdList></Reference><Reference><Citation>Philips T., Rothstein J.D. Rodent Models of Amyotrophic Lateral Sclerosis. Curr. Protoc. Pharmacol. 2015;69 doi: 10.1002/0471141755.ph0567s69.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/0471141755.ph0567s69</ArticleId><ArticleId IdType="pmc">PMC4562058</ArticleId><ArticleId IdType="pubmed">26344214</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreau C., Gosset P., Kluza J., Brunaud-Danel V., Lassalle P., Marchetti P., Defebvre L., Dest&#xe9;e A., Devos D.P. Deregulation of the hypoxia inducible factor-1&#x3b1; pathway in monocytes from sporadic amyotrophic lateral sclerosis patients. Neuroscience. 2011;172:110&#x2013;117. doi: 10.1016/j.neuroscience.2010.10.040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2010.10.040</ArticleId><ArticleId IdType="pubmed">20977930</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z., Yan J., Chang Y., ShiDu Yan S., Shi H. Hypoxia inducible factor-1 as a target for neurodegenerative diseases. Curr. Med. Chem. 2011;18:4335&#x2013;4343. doi: 10.2174/092986711797200426.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/092986711797200426</ArticleId><ArticleId IdType="pmc">PMC3213300</ArticleId><ArticleId IdType="pubmed">21861815</ArticleId></ArticleIdList></Reference><Reference><Citation>Semenza G.L. Hypoxia-inducible factor 1: Regulator of mitochondrial metabolism and mediator of ischemic preconditioning. Biochim. Biophys. Acta (BBA) Bioenerg. 2010;1813:1263&#x2013;1268. doi: 10.1016/j.bbamcr.2010.08.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbamcr.2010.08.006</ArticleId><ArticleId IdType="pmc">PMC3010308</ArticleId><ArticleId IdType="pubmed">20732359</ArticleId></ArticleIdList></Reference><Reference><Citation>Skene P., Cleveland D.W. Hypoxia and Lou Gehrig. Nat. Genet. 2001;28:107&#x2013;108. doi: 10.1038/88805.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/88805</ArticleId><ArticleId IdType="pubmed">11381249</ArticleId></ArticleIdList></Reference><Reference><Citation>Tankersley C.G., Haenggeli C., Rothstein J.D. Respiratory impairment in a mouse model of amyotrophic lateral sclerosis. J. Appl. Physiol. 2007;102:926&#x2013;932. doi: 10.1152/japplphysiol.00193.2006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/japplphysiol.00193.2006</ArticleId><ArticleId IdType="pubmed">17110520</ArticleId></ArticleIdList></Reference><Reference><Citation>Cimini S., Rizzardini M., Biella G., Cantoni L. Hypoxia causes autophagic stress and derangement of metabolic adaptation in a cell model of amyotrophic lateral sclerosis. J. Neurochem. 2014;129:413&#x2013;425. doi: 10.1111/jnc.12642.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.12642</ArticleId><ArticleId IdType="pubmed">24359187</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanacore N., Cocco P., Fadda D., Dosemeci M. Job strain, hypoxia and risk of amyotrophic lateral sclerosis: Results from a death certificate study. Amyotroph. Lateral Scler. 2010;11:430&#x2013;434. doi: 10.3109/17482961003605796.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482961003605796</ArticleId><ArticleId IdType="pubmed">20698805</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothstein J.D. Edaravone: A new drug approved for ALS. Cell. 2017;171:725. doi: 10.1016/j.cell.2017.10.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2017.10.011</ArticleId><ArticleId IdType="pubmed">29100067</ArticleId></ArticleIdList></Reference><Reference><Citation>Morello G., Spampinato A.G., Conforti F., D&#x2019;Agata V., Cavallaro S. Selection and Prioritization of Candidate Drug Targets for Amyotrophic Lateral Sclerosis Through a Meta-Analysis Approach. J. Mol. Neurosci. 2017;61:563&#x2013;580. doi: 10.1007/s12031-017-0898-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12031-017-0898-9</ArticleId><ArticleId IdType="pmc">PMC5359376</ArticleId><ArticleId IdType="pubmed">28236105</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaudry H., Falluel-Morel A., Bourgault S., Basille M., Burel D., Wurtz O., Fournier A., Chow B.K.C., Hashimoto H., Galas L., et al. Pituitary Adenylate Cyclase-Activating Polypeptide and Its Receptors: 20 Years after the Discovery. Pharmacol. Rev. 2009;61:283&#x2013;357. doi: 10.1124/pr.109.001370.</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/pr.109.001370</ArticleId><ArticleId IdType="pubmed">19805477</ArticleId></ArticleIdList></Reference><Reference><Citation>Reglodi D., Lubics A., Tam&#xe1;s A., Szalontay L., Lengv&#xe1;ri I. Pituitary adenylate cyclase activating polypeptide protects dopaminergic neurons and improves behavioral deficits in a rat model of Parkinson&#x2019;s disease. Behav. Brain Res. 2004;151:303&#x2013;312. doi: 10.1016/j.bbr.2003.09.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbr.2003.09.007</ArticleId><ArticleId IdType="pubmed">15084446</ArticleId></ArticleIdList></Reference><Reference><Citation>Reglodi D., Kiss P., Lubics A., Tamas A. Review on the protective effects of PACAP in models of neurodegenerative diseases in vitro and in vivo. Curr. Pharm. Des. 2011;17:962&#x2013;972. doi: 10.2174/138161211795589355.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/138161211795589355</ArticleId><ArticleId IdType="pubmed">21524257</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Amico A.G., Maugeri G., Reitano R., Bucolo C., Saccone S., Drago F., D&#x2019;Agata V. PACAP Modulates Expression of Hypoxia-Inducible Factors in Streptozotocin-Induced Diabetic Rat Retina. J. Mol. Neurosci. 2015;57:501&#x2013;509. doi: 10.1007/s12031-015-0621-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12031-015-0621-7</ArticleId><ArticleId IdType="pubmed">26202258</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Amico A.G., Maugeri G., Ras&#xe0; D.M., Bucolo C., Saccone S., Federico C., Cavallaro S., D&#x2019;Agata V. Modulation of IL-1&#x3b2; and VEGF expression in rat diabetic retinopathy after PACAP administration. Peptides. 2017;97:64&#x2013;69. doi: 10.1016/j.peptides.2017.09.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.peptides.2017.09.014</ArticleId><ArticleId IdType="pubmed">28964802</ArticleId></ArticleIdList></Reference><Reference><Citation>Maugeri G., D&#x2019;Amico A.G., Saccone S., Federico C., Cavallaro S., D&#x2019;Agata V. PACAP and VIP Inhibit HIF-1&#x3b1;-Mediated VEGF Expression in a Model of Diabetic Macular Edema. J. Cell. Physiol. 2016;232:1209&#x2013;1215. doi: 10.1002/jcp.25616.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.25616</ArticleId><ArticleId IdType="pubmed">27661459</ArticleId></ArticleIdList></Reference><Reference><Citation>Maugeri G., Longo A., D&#x2019;Amico A.G., Ras&#xe0; D.M., Reibaldi M., Russo A., Bonfiglio V., Avitabile T., D&#x2019;Agata V. Trophic effect of PACAP on human corneal endothelium. Peptides. 2018;99:20&#x2013;26. doi: 10.1016/j.peptides.2017.11.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.peptides.2017.11.003</ArticleId><ArticleId IdType="pubmed">29126993</ArticleId></ArticleIdList></Reference><Reference><Citation>Rat D., Schmitt U., Tippmann F., Dewachter I., Theunis C., Wieczerzak E., Postina R., Van Leuven F., Fahrenholz F., Kojro E. Neuropeptide pituitary adenylate cyclase-activating polypeptide (PACAP) slows down Alzheimer&#x2019;s disease-like pathology in amyloid precursor protein-transgenic mice. FASEB J. 2011;25:3208&#x2013;3218. doi: 10.1096/fj.10-180133.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.10-180133</ArticleId><ArticleId IdType="pmc">PMC3157688</ArticleId><ArticleId IdType="pubmed">21593432</ArticleId></ArticleIdList></Reference><Reference><Citation>Regl&#xf3;di D., Tam&#xe1;s A., Lengv&#xe1;ri I., Toth G., Szalontay L., Lubics A. Comparative study of the effects of PACAP in young, aging, and castrated males in a rat model of Parkinson&#x2019;s disease. Ann. N. Y. Acad. Sci. 2006;1070:518&#x2013;524. doi: 10.1196/annals.1317.072.</Citation><ArticleIdList><ArticleId IdType="doi">10.1196/annals.1317.072</ArticleId><ArticleId IdType="pubmed">16888218</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y.Z., Hannibal J., Zhao Q., Moller K., Danielsen N., Fahrenkrug J., Sundler F. Pituitary adenylate cyclase activating peptide expression in the rat dorsal root ganglia: Upregulation after peripheral nerve injury. Neuroscience. 1996;74:1099&#x2013;1110. doi: 10.1016/0306-4522(96)00168-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0306-4522(96)00168-6</ArticleId><ArticleId IdType="pubmed">8895878</ArticleId></ArticleIdList></Reference><Reference><Citation>Suarez V., Guntinas-Lichius O., Streppel M., Ingorokva S., Grosheva M., Neiss W.F., Angelov D.N., Klimaschewski L. The axotomy-induced neuropeptides galanin and pituitary adenylate cyclase-activating peptide promote axonal sprouting of primary afferent and cranial motor neurones. Eur. J. Neurosci. 2006;24:1555&#x2013;1564. doi: 10.1111/j.1460-9568.2006.05029.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1460-9568.2006.05029.x</ArticleId><ArticleId IdType="pubmed">17004919</ArticleId></ArticleIdList></Reference><Reference><Citation>Armstrong B., Abad C., Chhith S., Cheung-Lau G., Hajji O., Nobuta H., Waschek J.A. Impaired nerve regeneration and enhanced neuroinflammatory response in mice lacking pituitary adenylyl cyclase activating peptide. Neuroscience. 2007;151:63&#x2013;73. doi: 10.1016/j.neuroscience.2007.09.084.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2007.09.084</ArticleId><ArticleId IdType="pmc">PMC2245872</ArticleId><ArticleId IdType="pubmed">18055122</ArticleId></ArticleIdList></Reference><Reference><Citation>Pettersson L.M., Dahlin L.B., Danielsen N. Changes in expression of PACAP in rat sensory neurons in response to sciatic nerve compression. Eur. J. Neurosci. 2004;20:1838&#x2013;1848. doi: 10.1111/j.1460-9568.2004.03644.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1460-9568.2004.03644.x</ArticleId><ArticleId IdType="pubmed">15380005</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomimatsu N., Arakawa Y. Survival-promoting activity of pituitary adenylate cyclase-activating polypeptide in the presence of phosphodiesterase inhibitors on rat motoneurons in culture: cAMP-protein kinase A-mediated survival. J. Neurochem. 2008;107:628&#x2013;635. doi: 10.1111/j.1471-4159.2008.05638.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2008.05638.x</ArticleId><ArticleId IdType="pubmed">18717811</ArticleId></ArticleIdList></Reference><Reference><Citation>Ringer C., B&#xfc;ning L.-S., Sch&#xe4;fer M.K., Eiden L.E., Weihe E., Sch&#xfc;tz B. PACAP signaling exerts opposing effects on neuroprotection and neuroinflammation during disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis. Neurobiol. Dis. 2013;54:32&#x2013;42. doi: 10.1016/j.nbd.2013.02.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2013.02.010</ArticleId><ArticleId IdType="pmc">PMC3955759</ArticleId><ArticleId IdType="pubmed">23466699</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonaventura G., Iemmolo R., D&#x2019;Amico A.G., La Cognata V., Costanzo E., Zappia M., D&#x2019;Agata V., Conforti F., Aronica E., Cavallaro S. PACAP and PAC1R are differentially expressed in motor cortex of amyotrophic lateral sclerosis patients and support survival of iPSC-derived motor neurons. J. Cell. Physiol. 2017;233:3343&#x2013;3351. doi: 10.1002/jcp.26182.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.26182</ArticleId><ArticleId IdType="pubmed">28926110</ArticleId></ArticleIdList></Reference><Reference><Citation>Maugeri G., D&#x2019;Amico A.G., Ras&#xe0; D.M., Federico C., Saccone S., Morello G., La Cognata V., Cavallaro S., D&#x2019;Agata V. Molecular mechanisms involved in the protective effect of pituitary adenylate cyclase-activating polypeptide in an in vitro model of amyotrophic lateral sclerosis. J. Cell. Physiol. 2018;234:5203&#x2013;5521. doi: 10.1002/jcp.27328.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.27328</ArticleId><ArticleId IdType="pubmed">30238989</ArticleId></ArticleIdList></Reference><Reference><Citation>Arciello M., Capo C.R., Cozzolino M., Ferri A., Nencini M., Carri M.T., Rossi L. Inactivation of cytochromecoxidase by mutant SOD1s in mouse motoneuronal NSC-34 cells is independent from copper availability but is because of nitric oxide. J. Neurochem. 2010;112:183&#x2013;192. doi: 10.1111/j.1471-4159.2009.06441.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2009.06441.x</ArticleId><ArticleId IdType="pubmed">19845829</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsuragi Y., Ichimura Y., Komatsu M. p62/SQSTM1 functions as a signaling hub and an autophagy adaptor. FEBS J. 2015;282:4672&#x2013;4678. doi: 10.1111/febs.13540.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/febs.13540</ArticleId><ArticleId IdType="pubmed">26432171</ArticleId></ArticleIdList></Reference><Reference><Citation>Barth S., Glick D., MacLeod K. Autophagy: Assays and artifacts. J. Pathol. 2010;221:117&#x2013;124. doi: 10.1002/path.2694.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.2694</ArticleId><ArticleId IdType="pmc">PMC2989884</ArticleId><ArticleId IdType="pubmed">20225337</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanida I., Ueno T., Kominami E. LC3 conjugation system in mammalian autophagy. Int. J. Biochem. Cell Boil. 2004;36:2503&#x2013;2518. doi: 10.1016/j.biocel.2004.05.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biocel.2004.05.009</ArticleId><ArticleId IdType="pmc">PMC7129593</ArticleId><ArticleId IdType="pubmed">15325588</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters O.M., Ghasemi M., Brown R.H. Emerging mechanisms of molecular pathology in ALS. J. Clin. Investig. 2015;125:1767&#x2013;1779. doi: 10.1172/JCI71601.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI71601</ArticleId><ArticleId IdType="pmc">PMC4463186</ArticleId><ArticleId IdType="pubmed">25932674</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubinsztein D.C. The roles of intracellular protein-degradation pathways in neurodegeneration. Nature. 2006;443:780&#x2013;786. doi: 10.1038/nature05291.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature05291</ArticleId><ArticleId IdType="pubmed">17051204</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J., Kim T.-Y., Cho K.-S., Na Kim H., Koh J.-Y. Autophagy activation and neuroprotection by progesterone in the G93A-SOD1 transgenic mouse model of amyotrophic lateral sclerosis. Neurobiol. Dis. 2013;59:80&#x2013;85. doi: 10.1016/j.nbd.2013.07.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2013.07.011</ArticleId><ArticleId IdType="pubmed">23891729</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S., Zhang X., Song L., Le W. Autophagy Dysregulation in Amyotrophic Lateral Sclerosis. Brain Pathol. 2011;22:110&#x2013;116. doi: 10.1111/j.1750-3639.2011.00546.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1750-3639.2011.00546.x</ArticleId><ArticleId IdType="pubmed">22150926</ArticleId></ArticleIdList></Reference><Reference><Citation>Valbuena G., Rizzardini M., Cimini S., Siskos A., Bendotti C., Cantoni L., Keun H. Metabolomic Analysis Reveals Increased Aerobic Glycolysis and Amino Acid Deficit in a Cellular Model of Amyotrophic Lateral Sclerosis. Mol. Neurobiol. 2015;53:2222&#x2013;2240. doi: 10.1007/s12035-015-9165-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-015-9165-7</ArticleId><ArticleId IdType="pmc">PMC4823370</ArticleId><ArticleId IdType="pubmed">25963727</ArticleId></ArticleIdList></Reference><Reference><Citation>Shvets E., Fass E., Scherz-Shouval R., Elazar Z. The N-terminus and Phe52 residue of LC3 recruit p62/SQSTM1 into autophagosomes. J. Cell Sci. 2008;121:2685&#x2013;2695. doi: 10.1242/jcs.026005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.026005</ArticleId><ArticleId IdType="pubmed">18653543</ArticleId></ArticleIdList></Reference><Reference><Citation>Gal J., Strom A.-L., Kwinter D.M., Kilty R., Zhang J., Shi P., Fu W., Wooten M.W., Zhu H. Sequestosome 1/p62 links familial ALS mutant SOD1 to LC3 via an ubiquitin-independent mechanism. J. Neurochem. 2009;111:1062&#x2013;1073. doi: 10.1111/j.1471-4159.2009.06388.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2009.06388.x</ArticleId><ArticleId IdType="pmc">PMC2766427</ArticleId><ArticleId IdType="pubmed">19765191</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Q., Zhang J., Li S., Chen S., Le W. n-butylidenephthalide treatment prolongs life span and attenuates motor neuron loss in SOD1G93A mouse model of amyotrophic lateral sclerosis. CNS Neurosci. Ther. 2017;23:375&#x2013;385. doi: 10.1111/cns.12681.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cns.12681</ArticleId><ArticleId IdType="pmc">PMC6492644</ArticleId><ArticleId IdType="pubmed">28229532</ArticleId></ArticleIdList></Reference><Reference><Citation>Cashman N.R., Durham H.D., Blusztajn J.K., Oda K., Tabira T., Shaw I.T., Dahrouge S., Antel J.P. Neuroblastoma x spinal cord (NSC) hybrid cell lines resemble developing motor neurons. Dev. Dyn. 1992;194:209&#x2013;221. doi: 10.1002/aja.1001940306.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/aja.1001940306</ArticleId><ArticleId IdType="pubmed">1467557</ArticleId></ArticleIdList></Reference><Reference><Citation>Hunter D., Cashman N., Morris-Valero R., Bulock J., Adams S., Sanes J. An LRE (leucine-arginine-glutamate)-dependent mechanism for adhesion of neurons to S-laminin. J. Neurosci. 1991;11:3960&#x2013;3971. doi: 10.1523/JNEUROSCI.11-12-03960.1991.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.11-12-03960.1991</ArticleId><ArticleId IdType="pmc">PMC6575296</ArticleId><ArticleId IdType="pubmed">1683902</ArticleId></ArticleIdList></Reference><Reference><Citation>Eggett C.J., Crosier S., Manning P., Cookson M.R., Menzies F.M., McNeil C.J., Shaw P.J. Development and Characterisation of a Glutamate-Sensitive Motor Neurone Cell Line. J. Neurochem. 2008;74:1895&#x2013;1902. doi: 10.1046/j.1471-4159.2000.0741895.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1471-4159.2000.0741895.x</ArticleId><ArticleId IdType="pubmed">10800932</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Amico A.G., Maugeri G., Ras&#xe0; D.M., La Cognata V., Saccone S., Federico C., Cavallaro S., D&#x2019;Agata V. NAP counteracts hyperglycemia/hypoxia induced retinal pigment epithelial barrier breakdown through modulation of HIFs and VEGF expression. J. Cell. Physiol. 2017;233:1120&#x2013;1128. doi: 10.1002/jcp.25971.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.25971</ArticleId><ArticleId IdType="pubmed">28436035</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Amico A.G., Maugeri G., Magro G., Salvatorelli L., Drago F., D&#x2019;Agata V. Expression pattern of parkin isoforms in lung adenocarcinomas. Tumor Boil. 2015;36:5133&#x2013;5141. doi: 10.1007/s13277-015-3166-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13277-015-3166-z</ArticleId><ArticleId IdType="pubmed">25656612</ArticleId></ArticleIdList></Reference><Reference><Citation>Maugeri G., D&#x2019;Amico A.G., Ras&#xe0; D.M., Saccone S., Federico C., Cavallaro S., D&#x2019;Agata V. PACAP and VIP regulate hypoxia-inducible factors in neuroblastoma cells exposed to hypoxia. Neuropeptides. 2018;69:84&#x2013;91. doi: 10.1016/j.npep.2018.04.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.npep.2018.04.009</ArticleId><ArticleId IdType="pubmed">29699729</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>